9:45am ET
Health and Healthcare
Major Biotechs Get Mixed Message on Short Interest
The March 13 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
Companies
/Healthcare
AMGEN Inc
$377.35
▼ $5.12 (−1.34%) today
Markets closed · 1:54pm ET
AMGN Coverage
Page 13
9:13am ET
Health and Healthcare
Big Biotechs Have Short Sellers Confused
The February 28 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
8:35am ET
Health and Healthcare
Major Biotechs Have Short Sellers Confused
The February 14 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
7:35am ET
Investing
15 Top ESG Stocks That Look Undervalued for 2020
With billions of dollars flowing in, it has become impossible to ignore the ESG trend. These 15 top ESG stocks appear to be undervalued against the performance of the broader markets.
8:45am ET
Health and Healthcare
Biotech Short Sellers Focus on a Couple Favorites
The January 31 data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Boeing, Etsy, Gilead, GoPro, Micron, Newmont, Peloton, Pfizer, Valero, Zynga and More
Thursday's top analyst upgrades, downgrades and initiations included AbbVie, Biogen, Boeing, Etsy, Gilead Sciences, GoPro, Micron Technology, Newmont, Peloton Interactive, Pfizer, Valero Energy and Zynga.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Aimmune, Amgen, Biogen, Chevron, CRISPR, Exxon, Nike, Snap, Uber, Ulta, Verizon and More
Monday's top analyst upgrades, downgrades and initiations included Aimmune Therapeutics, Amgen, Biogen, Chevron, CRISPR, Exxon Mobil, Nike, Snap, Uber, Ulta Beauty and Verizon.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: AGNC, Amazon, Amgen, Coca-Cola, Danaher, EA, IBM, Miragen, Proofpoint, Sprint, UPS, Uber, Vertex, Visa and More
Friday's top analyst upgrades, downgrades and initiations included Amazon.com, Amgen, Coca-Cola, Danaher, Electronic Arts, IBM, Proofpoint, Sprint, UPS, Uber, Vertex Pharmaceuticals and Visa.
8:45am ET
Health and Healthcare
Short Sellers Wary on Major Biotechs
The January 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
7:10am ET
Investing
Amazon, Facebook, Starbucks, Tesla and More Major Earnings Coming This Week
24/7 Wall St. has put together a preview of the most prominent earnings reports this week, including Amazon.com, AT&T and General Electric.
1:35pm ET
Health and Healthcare
How Earnings Will Dictate Biotech Sector’s Fate in 2020
Why Credit Suisse believes that this round of quarterly biotech earnings could prove to be a catalyst for 2020.
8:40am ET
Health and Healthcare
Major Biotechs Have Short Sellers Excited
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
8:40am ET
Health and Healthcare
Major Biotechs See Rising Short Interest
The December 13 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
9:00am ET
Investing
Top Analyst Upgrades and Downgrades: Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron, Sarpeta and More
Christmas Eve's top analyst upgrades, downgrades and initiations included Amgen, Apple, Builder FirstSource, CarMax, Dominion Energy, FedEx, Nike, Regeneron Pharmaceuticals and Sarpeta Therapeutics.
7:55am ET
Health and Healthcare
Allergan Gets FDA Approval for Migraine Treatment
The FDA has approved Allergan's treatment for migraines in adults. The drug is the first of its class to obtain FDA approval, but the new drug will compete with other recently released…
